Kellen Winslow had a Staph Infection and speaks out against Cleveland Browns Facilities.

Researchers at the University of Washington have uncovered how the bacterium Staphylococcus aureus, including the notorious MRSA (methicillin-resistant Staph aureus) “superbug” strains, resists our body's natural defenses against infection. The work, which was featured on the cover of the March 21 issue of Science, could lead to new ways to fight the bacteria.

Pneumonia contracted outside a hospital caused by a staph bacterium, including a "superbug" strain, may be more common in U.S. children than previously thought.

An international team of researchers supported by the National Institutes of Health (NIH) has blocked staph infections in mice using a drug previously tested in clinical trials as a cholesterol-lowering agent.

California’s authorities have issued an order for hospitals to report incidents of staph infection that lead to lethal outcome or intensive medical aid for patients.

One of the ways we defend ourselves against bacterial foes is to “hide” their food, particularly the metals they crave. A multi-disciplinary team led by Vanderbilt University investigators has now discovered that a protein inside certain immune system cells blocks the growth of “staph” bacteria by sopping up manganese and zinc.

One type of over-the-counter product for topical wound care is more effective than others in killing methicillin-resistant Staphylococcus aureus bacteria, or MRSA, which is potentially deadly and in recent years has moved from its historic hospital setting to a much broader public concern.

Newly described proteins in drug-resistant strains of the Staphylococcus aureus bacterium attract and then destroy protective human white blood cells—a key process ensuring that S. aureus survives and causes severe disease, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

University of Idaho researchers are crossing academic and geographical bounds to develop more effective defenses against Staphylococcus aureus bacteria and other deadly pathogens.

In hopes of combating the growing scourge of antibiotic-resistant bacteria, in particular drug-resistant staph bacteria, a team of scientists from the Scripps Research Institute has designed a new type of vaccine that could one day be used in humans to block the onset of infection.

Governor of Virginia Timothy M. Kaine today approved an emergency regulation by the State Health Commissioner that requires laboratories to report Methicillin-resistant Staphylococcus aureus (MRSA) infection to the Virginia Department of Health (VDH). The regulation is effective today, and will assist public health authorities in the effort to compile data on the prevalence of MRSA for surveillance and investigation.

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) appears to be more prevalent than previously believed, affecting certain populations disproportionately and is being found more often outside of health care settings, according to a study in the October 17 issue of JAMA.